RIPK1- and RIPK3-induced cell death mode is determined by target availability

W D Cook1, D M Moujalled2, T J Ralph1

  • 1La Trobe Institute for Molecular Science, La Trobe University, Kingsbury Drive, Bundoora, Victoria 3086, Australia.

Insights

Receptor-interacting protein kinases (RIPK1 and RIPK3) trigger cell death. Their activation mode, independent of death ligands, depends on downstream protein availability, not a simple switch.

Area of Science:

  • Cellular Biology
  • Molecular Biology
  • Immunology

Background:

  • Receptor-interacting protein kinase 1 (RIPK1) and RIPK3 are key regulators of programmed cell death.
  • Understanding RIPK-triggered cell death independent of death receptor signaling is crucial for disease research.

Purpose of the Study:

  • To investigate the signaling requirements for RIPK1 and RIPK3-induced cell death in the absence of death receptor ligands.
  • To elucidate the mechanisms by which RIPK1 and RIPK3 activate distinct cell death pathways.

Main Methods:

  • Engineered inducible versions of RIPK1 and RIPK3 activated by dimerization with coumermycin.
  • Studied cell death mechanisms in the absence of TNF or other death ligands.
  • Assessed the roles of FADD, caspase 8, and MLKL in RIPK-mediated cell death.

Main Results:

  • RIPK1 dimerization induced cell death via caspase- or RIPK3-dependent pathways.
  • RIPK3 dimerization triggered MLKL-dependent death and also FADD, caspase 8, and RIPK1-mediated death.
  • RIPK3 kinase activity was essential for MLKL-dependent but not caspase 8-dependent death.

Conclusions:

  • The mode of RIPK-induced cell death is determined by the availability of downstream signaling molecules like FADD, caspase 8, and MLKL.
  • RIPK-mediated cell death does not operate via a simple switch but is modulated by the levels of signaling and effector proteins.

Related Concept Videos

Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
5.2K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.2K
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
7.6K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.2K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.2K